Mallol, J. et al. International prevalence of recurrent wheezing during the first year of life: Variability, treatment patterns and use of health resources. Thorax 65, 1004–1009, https://doi.org/10.1136/thx.2009.115188 (2010).
Ly, N. P., Gold, D. R., Weiss, S. T. & Celedón, J. C. Recurrent wheeze in early childhood and asthma among children at risk for atopy. Pediatrics 117, e1132–e1138, https://doi.org/10.1542/peds.2005-2271 (2006).
Leader, S. & Kohlhase, K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J. Pediatr. 143, 127–132, https://doi.org/10.1067/S0022-3476(03)00510-9 (2003).
Chang, A. B., Chang, C. C., O’Grady, K. & Torzillo, P. J. Lower respiratory tract infections. Pediatr. Clin. North Am. 56, 1303–1321, https://doi.org/10.1016/j.pcl.2009.09.003 (2009).
Zorc, J. J. & Hall, C. B. Bronchiolitis: Recent evidence on diagnosis and management. Pediatrics 125, 342–349, https://doi.org/10.1542/peds.2009-2092 (2010).
Jartti, T. & Korppi, M. Rhinovirus-induced bronchiolitis and asthma development. Pediatr. Allergy Immunol. 22, 350–355, https://doi.org/10.1111/j.1399-3038.2011.01170.x (2011).
Beigelman, A. & Bacharier, L. B. The role of early life viral bronchiolitis in the inception of asthma. Curr. Opin. Allergy Clin. Immunol. 13, 211–216, https://doi.org/10.1097/ACI.0b013e32835eb6ef (2013).
Article CAS PubMed PubMed Central Google Scholar
Bisgaard, H. & Szefler, S. Prevalence of asthma-like symptoms in young children. Pediatr. Pulmonol. 42, 723–728, https://doi.org/10.1002/ppul.20644 (2007).
Beigelman, A. et al. Randomized trial to evaluate azithromycin’s effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. J. Allergy Clin. Immunol. 135, 1171–1178.e1, https://doi.org/10.1016/j.jaci.2014.10.001 (2015).
Article CAS PubMed Google Scholar
McCallum G. B. et al. Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: A multicentre, randomized, placebo-controlled trial. Front Pediatr. 3. https://doi.org/10.3389/fped.2015.00032 (2015).
Mummidi, P. S., Tripathy, R., Dwibedi, B., Mahapatra, A. & Baraha, S. Viral aetiology of wheezing in children under five. Indian J. Med. Res. 145, 189–193, https://doi.org/10.4103/ijmr.IJMR_840_15 (2017).
Article CAS PubMed PubMed Central Google Scholar
Bisgaard, H. et al. Association of bacteria and viruses with wheezy episodes in young children: Prospective birth cohort study. BMJ (Online) 341, 770, https://doi.org/10.1136/bmj.c4978 (2010).
Martinez, F. Role of macrolide therapy in chronic obstructive pulmonary disease. Int J. Chron. Obstruct Pulmon Dis. ume 3, 331–350, https://doi.org/10.2147/COPD.S681 (2008).
Ghimire, J. J. et al. Azithromycin for poorly controlled asthma in children. Chest 161, 1456–1464, https://doi.org/10.1016/j.chest.2022.02.025 (2022).
Article CAS PubMed Google Scholar
Pinto, L. A. et al. Effect of clarithromycin on the cell profile of bronchoalveolar lavage fluid in mice with neutrophil-predominant lung disease. Rev. Hosp. Clin. Fac. Med Sao Paulo 59, 99–103, https://doi.org/10.1590/S0041-87812004000300002 (2004).
Friedlander, A. L. & Albert, R. K. Chronic Macrolide Therapy in Inflammatory Airways Diseases. Chest 138, 1202–1212, https://doi.org/10.1378/chest.10-0196 (2010).
Article CAS PubMed Google Scholar
Kanoh, S. & Rubin, B. K. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin. Microbiol Rev. 23, 590–615, https://doi.org/10.1128/CMR.00078-09 (2010).
Article CAS PubMed PubMed Central Google Scholar
Bacharier, L. B. et al. Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses. JAMA 314, 2034, https://doi.org/10.1001/jama.2015.13896 (2015).
Article CAS PubMed PubMed Central Google Scholar
Kricker, J. A. et al. NoNantimicrobial Actions Of Macrolides: Overview and perspectives for future development. Pharm. Rev. 73, 1404–1433, https://doi.org/10.1124/pharmrev.121.000300 (2021).
Halldorsson, S. et al. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 42, 62–68, https://doi.org/10.1165/rcmb.2008-0357OC (2010).
Article CAS PubMed Google Scholar
Luisi, F. L. et al. Azithromycin administered for acute bronchiolitis may have a protective effect on subsequent wheezing. J. Brasileiro de. Pneumologia 46, e20180376–e20180376, https://doi.org/10.36416/1806-3756/e20180376 (2020).
Stokholm, J. et al. Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years: a randomised, double-blind, placebo-controlled trial. Lancet Respir. Med. 4, 19–26, https://doi.org/10.1016/S2213-2600(15)00500-7 (2016).
Article CAS PubMed Google Scholar
Kneyber, M. C. J., van Woensel, J. B. M., Uijtendaal, E., Uiterwaal, C. S. P. M. & Kimpen, J. L. L. Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: A randomized equivalence trial. Pediatr. Pulmonol. 43, 142–149, https://doi.org/10.1002/ppul.20748 (2008).
Kong, M. et al. Azithromycin treatment vs placebo in children with respiratory syncytial virus–induced respiratory failure. JAMA Netw. Open 3, e203482, https://doi.org/10.1001/jamanetworkopen.2020.3482 (2020).
Article PubMed PubMed Central Google Scholar
Simoes, E. A. F. et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J. Pediatr. 151, 34–42.e1, https://doi.org/10.1016/j.jpeds.2007.02.032 (2007).
Article CAS PubMed Google Scholar
Yoshihara, S. et al. Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. Pediatrics 132, 811–818, https://doi.org/10.1542/peds.2013-0982 (2013).
Zhou, Y. et al. Azithromycin therapy during respiratory syncytial virus bronchiolitis: Upper airway microbiome alterations and subsequent recurrent wheeze. J. Allergy Clin. Immunol. 138, 1215–1219.e5, https://doi.org/10.1016/j.jaci.2016.03.054 (2016).
Article CAS PubMed PubMed Central Google Scholar
Teo, S. M. et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 17, 704–715, https://doi.org/10.1016/j.chom.2015.03.008 (2015).
Article CAS PubMed PubMed Central Google Scholar
Teo, S. M. et al. Airway microbiota dynamics uncover a critical window for interplay of pathogenic bacteria and allergy in childhood respiratory disease. Cell Host Microbe 24, 341–352.e5, https://doi.org/10.1016/j.chom.2018.08.005 (2018).
Article CAS PubMed PubMed Central Google Scholar
Beigelman A. et al. Azithromycin to prevent recurrent wheeze following severe respiratory syncytial virus bronchiolitis. NEJM Evid. 1. https://doi.org/10.1056/EVIDoa2100069 (2022).
Matzneller, P. et al. Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy. Antimicrob. Agents Chemother. 57, 1736–1742, https://doi.org/10.1128/AAC.02011-12 (2013).
Article CAS PubMed PubMed Central Google Scholar
Porsbjerg, C., Melén, E., Lehtimäki, L. & Shaw, D. Asthma. Lancet 401, 858–873, https://doi.org/10.1016/S0140-6736(22)02125-0 (2023).
McCallum, G. B. et al. A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: A randomised, placebo-controlled trial. PLoS One 8, e74316, https://doi.org/10.1371/journal.pone.0074316 (2013).
Comments (0)